Intestinal Cell Regeneration Trigger Identified

Intestinal Cell Regeneration Trigger Identified

Researchers at the University of Colorado Anschutz Medical Campus have identified a crucial biochemical process called H3K36 methylation that acts as a “switch” for intestinal cell regeneration after injury. This process controls whether normal intestinal cells can revert to a regenerative stem cell state. The discovery, published in Nature Cell Biology, reveals that H3K36 methylation must be removed for cells to dedifferentiate and […]

Celularity and BlueSphere Bio Collaborate on Cell Therapy Manufacturing

Celularity and BlueSphere Bio Collaborate on Cell Therapy Manufacturing

Celularity Inc., a cellular medicine company, has entered into a collaboration agreement with BlueSphere Bio (BSB).? Celularity will leverage its manufacturing capabilities to produce BSB’s T cell receptor (TCR) T cell therapies.? This partnership will focus on manufacturing and quality control at Celularity’s New Jersey facility for BSB’s therapies, including a treatment for Acute Myelogenous […]

Genetically Engineered Stem Cells Fight Gastroesophageal Cancer

Genetically Engineered Stem Cells Fight Gastroesophageal Cancer

Dr. Saar Gill of the University of Pennsylvania received a $450,000 grant from the DeGregorio Family Foundation to continue research on genetically engineered stem cells to combat gastroesophageal cancer. This builds upon previous work using Chimeric Antigen Receptor (CAR) macrophages to target and destroy cancer cells within solid tumors. The ultimate goal is to develop a long-lasting supply of cancer-fighting cells. […]

Newton Rallies to Save Teen with Leukemia: Join the Stem Cell Donor Drive

Newton community holding stem cell donor drive for teen in need of transplant

In the small town of Newton, Kansas, the community is rallying together for a noble cause—a stem cell donor drive to help save the life of Jonah Huet, a 15-year-old high school student recently diagnosed with leukemia. Jonah, an avid volleyball player and passionate marching band member, urgently needs a stem cell transplant, but no […]

Eterna Therapeutics Investigates ERNA-101 in Cancer Models

Eterna Therapeutics Investigates ERNA-101 in Cancer Models

Eterna Therapeutics, a preclinical-stage company, announced a research collaboration with MD Anderson Cancer Center to evaluate its lead induced mesenchymal stem cell therapy, ERNA-101, for treating ovarian and breast cancers.  ERNA-101, a proprietary allogenic cell therapy, aims to stimulate antitumor immunity. The research will assess ERNA-101’s effects both in vitro and in vivo, with potential future studies exploring […]

Revolutionizing Cancer Treatment: The Impact of Stem Cell Transplants at Community Health Network MD Anderson Cancer Center

The Impact of Stem Cell Transplants at Community Health Network MD Anderson Cancer Center

At Community Health Network’s MD Anderson Cancer Center, a groundbreaking milestone has been reached with the center’s first stem cell transplant. This significant medical advancement involves the infusion of a patient’s own stem cells, which were harvested, frozen, and reintroduced after a high dose of chemotherapy. The procedure aims to restore the bone marrow and […]

Factor Bioscience and Eterna Therapeutics Partner to Accelerate Advanced Cell Therapies for Cancer, Rare Diseases, and Autoimmune Disorders

Factor Bioscience and Eterna Therapeutics Join Forces to Advance Treatments for Cancer, Autoimmune, and Rare Diseases

In a groundbreaking collaboration that promises to reshape the future of medicine, Factor Bioscience and Eterna Therapeutics have announced an exclusive license agreement to accelerate the development of stem cell-based therapies for oncology, autoimmune disorders, and rare diseases. The agreement is centered around the utilization of Factor’s proprietary induced pluripotent stem cell (iPSC) technologies, which […]

Unlocking the Future of Stem Cell Transplants: New Advances in Hematopoietic Cell Therapies

Dr. Michael Grunwald - Stem Cell Transplants research updates

In the video below, Dr. Michael Grunwald discusses the transformative potential of hematopoietic cell transplantation, also known as stem cell or bone marrow transplantation, particularly for patients with myeloproliferative neoplasms (MPNs). This advanced treatment, though not necessary for all MPN patients, offers a beacon of hope for a select group, leveraging the body’s immune system […]